Abstract:AbstractSirtuin 2 (SIRT2) is a member of the sirtuin family of NAD+‐dependent protein deacetylases. In recent years, SIRT2 inhibition has emerged as a promising treatment for neurodegenerative diseases. However, to date, there is no evidence of a specific role for SIRT2 in traumatic brain injury (TBI). We investigated the effects of SIRT2 inhibition on experimental TBI using the controlled cortical impact (CCI) injury model. Adult male mice underwent CCI or sham surgery. A selective brain‐permeable SIRT2 inhibitor, AK‐7, was administrated 30 min before injury. The volume of the brain edema lesion and the water content of the brain were significantly increased in mice treated with AK‐7 (20 mg/kg), compared with the vehicle group, following TBI (p < 0.05 at 1 day and p < 0.05 at 3 days, respectively). Concomitantly, AK‐7 administration greatly worsened neurobehavioral deficits on days 3 and 7 after CCI. Furthermore, blood–brain barrier disruption and matrix metalloproteinases (MMP)‐9 activity increased following SIRT2 inhibition. AK‐7 treatment increased TBI‐induced microglial activation both in vivo and in vitro, accompanied by a large increase in the expression and release of inflammatory cytokines. Mechanistically, SIRT2 inhibition increased both K310 acetylation and nuclear translocation of NF‐κB p65, leading to enhanced NF‐κB activation and up‐regulation of its target genes, including aquaporin 4 (AQP4), MMP‐9, and pro‐inflammatory cytokines. Together, these data demonstrate that SIRT2 inhibition exacerbates TBI by increasing NF‐κB p65 acetylation and activation. Our findings provide additional evidence of an anti‐inflammatory effect of SIRT2.image SIRT2 is a member of the sirtuin family of NAD+‐dependent protein deacetylases. Our study suggests that the SIRT2 inhibitor AK‐7 exacerbates traumatic brain injury (TBI) via a potential mechanism involving increased acetylation and nuclear translocation of NF‐κB p65, resulting in up‐regulation of NF‐κB target genes, including aquaporin 4 (AQP4), matrix metalloproteinase 9 (MMP‐9), and pro‐inflammatory cytokines. Our findings provide additional evidence of an anti‐inflammatory effect of SIRT2.

SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice

SIRT2 Inhibitors Can Induce Significant Increases in the Gene Expression of Pro‐inflammatory Factors in Primary Astrocyte Cultures

SIRT2 is Required for Lipopolysaccharide-Induced Activation of BV2 Microglia.

AGK2 Alleviates Lipopolysaccharide Induced Neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1

SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation.

<scp>SIRT</scp>2 inhibition exacerbates neuroinflammation and blood–brain barrier disruption in experimental traumatic brain injury by enhancing <scp>NF</scp>‐κB p65 acetylation and activation

SIRT2 Plays Complex Roles in Neuroinflammation Neuroimmunology-Associated Disorders

TRPM2 channel regulates cytokines production in astrocytes and aggravates brain disorder during lipopolysaccharide-induced endotoxin sepsis.

SIRT2 Plays a Key Role in Both Cell Cycle Regulation and Cell Survival of BV2 Microglia.

Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment Via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus.

Sirtuin 1 activator alleviated lethal inflammatory injury via promotion of autophagic degradation of pyruvate kinase M2

The Role of SIRT1 in Autophagy in Lipopolysaccharide-Induced Mouse Type II Alveolar Epithelial Cells

Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

Sirtuin 1 Alleviates Microglia-Induced Inflammation by Modulating the PGC-1α/Nrf2 Pathway after Traumatic Brain Injury in Male Rats

Knockout of Sirt2 Alleviates Traumatic Brain Injury in Mice

Effects of Sirtuin 1 on Microglia in Spinal Cord Injury

Inhibition of Cathepsin S Produces Neuroprotective Effects after Traumatic Brain Injury in Mice

CysLT 2 Receptor Mediates Lipopolysaccharide-Induced Microglial Inflammation and Consequent Neurotoxicity in Vitro

SIRT1 Promotes M2 Microglia Polarization via Reducing ROS-Mediated NLRP3 Inflammasome Signaling After Subarachnoid Hemorrhage

SIRT2 regulates high mobility group protein B1 nucleoplasmic shuttle and degradation via deacetylation in microglia

Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?